Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT04734626

CrCest Study in Primary Mitochondrial Disease

Sponsor: Children's Hospital of Philadelphia

View on ClinicalTrials.gov

Summary

The purpose of this study is to perform a "muscle phenotyping" magnetic resonance imaging (MRI) assessment in patients receiving clinical care at the Children's Hospital of Philadelphia (CHOP) for mitochondrial disease that is either suspected (based on clinical presentation) or has a definite genetic diagnosis. The MRI assessment quantifies skeletal muscle oxidative phosphorylation (OXPHOS) capacity. Investigators hope that this study will contribute to our current knowledge of mitochondrial diseases and this study will help create a new diagnostic tool for use in both clinical care and in clinical trials.

Official title: Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease

Key Details

Gender

All

Age Range

7 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

230

Start Date

2021-05-25

Completion Date

2028-12-31

Last Updated

2026-01-14

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Creatine Chemical Exchange Saturation Transfer (CrCEST) Imaging Sequence

CrCEST be used to assess creatine distribution and concentrations in muscle (lower extremity), both at rest and after recovery from a brief foot-pedal depression exercise

Locations (1)

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States